Balchem比2025年第4季度的收入估计数高,销售额、净收入和调整后的EPS均有所增加。 Balchem beat earnings estimates in Q4 2025 with higher sales, net income, and adjusted EPS.

Balchem公司报告了第四季度和全年的2025年财务结果,显示销售、净收入和每股收入年年增长。 Balchem Corporation reported fourth-quarter and full-year 2025 financial results, showing year-over-year growth in sales, net income, and earnings per share. Q4销售从2.4亿美元增加到2.6362亿美元,净收入增至3 923万美元。 Q4 sales rose to $263.62 million from $240 million, with net income increasing to $39.23 million. 持续业务中每个份额的稀释收入为1.21美元,高于1.03美元。 Diluted earnings per share from continuing operations were $1.21, up from $1.03. 全年销售额达10.37亿美元,比9.5368亿美元有所增加,净收入增至1.5485亿美元。 Full-year sales reached $1.037 billion, up from $953.68 million, and net income grew to $154.85 million. 该公司比分析师估计的Q4经调整的EPS增加2.34%,报告为1.31美元,而预计为1.28美元,收入为2.6756亿美元。 The company beat analyst estimates for Q4 adjusted EPS by 2.34%, reporting $1.31 versus a projected $1.28, with revenue at $267.56 million. 在过去四个季度里,Balchem一直超过预期。 Balchem has consistently exceeded expectations over the past four quarters.